About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Nvidia (NVDA.O) rose 5.64% in pre-market trading after the company's Q3 revenue and Q4 revenue outlook both exceeded market expectations.

2025-11-20

Nvidia (NVDA.O) rose 5.64% in pre-market trading after the company's Q3 revenue and Q4 revenue outlook both exceeded market expectations.

Other News
2025-11-20

Individual Stock News: 1. China International Capital Corporation (03908.HK): Plans to absorb and merge Dongxing Securities and Cinda Securities through a share swap. 2. Kuaishou (01024.HK): Q3 2025 revenue was RMB 35.554 billion, compared to RMB 3

Individual Stock News: 1. China International Capital Corporation (03908.HK): Plans to absorb and merge Dongxing Securities and Cinda Securities through a share swap. 2. Kuaishou (01024.HK): Q3 2025 revenue was RMB 35.554 billion, compared to RMB 31.13 billion in the same period last year; Q3 adjusted net profit was RMB 4.986 billion, a year-on-year increase of 26.3%. 3. Kingsoft Corporation (03888.HK): Q3 2025 revenue was RMB 2.42 billion, compared to RMB 2.915 billion in the same period last year; Q3 net profit was RMB 213 million, compared to RMB 413 million in the same period last year. 4. Kingsoft Cloud (03896.HK): Q3 total revenue reached RMB 2.478 billion, a year-on-year increase of 31.4% compared to RMB 1.886 billion in the same period of 2024. 5. GDS Holdings (09698.HK): Q3 2025 revenue was RMB 2.887 billion, compared to RMB 2.966 billion in the same period last year. 6. SF Holding (06936.HK): October's combined revenue from express delivery, supply chain, and international businesses reached RMB 26.454 billion, a year-on-year increase of 9.79%. 7. Wuling Motors (00305.HK) established a subsidiary focusing on low-speed intelligent driving systems and solutions. 8. QuantumCTek (00290.HK): Expects interim net profit attributable to shareholders to be approximately HKD 200 million to HKD 210 million, turning a profit year-on-year. 9. Baijin Life Sciences (01466.HK): Its subsidiary plans to invest in Youhuan Bio to build a world-leading circRNA technology R&D platform.
2025-11-20

Novartis: The expansion in North Carolina aims to increase production capacity and enable the company to produce 100% of its key medicines end-to-end in the United States.

Novartis: The expansion in North Carolina aims to increase production capacity and enable the company to produce 100% of its key medicines end-to-end in the United States.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2025 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD